TRPV1 is an ion channel protein found on pain-sensing nerve cells that acts as a molecular alarm for heat, acidity, and certain chemicals, most famously capsaicin, the compound that makes chili peppers burn. First cloned from rat neurons in 1997, it belongs to the transient receptor potential (TRP) family of channels and serves as a gatekeeper that opens when it detects a potentially harmful stimulus, allowing a flood of charged particles into the cell and triggering the sensation of burning pain. TRPV1’s reach extends well beyond spicy food, though, touching inflammation, body temperature regulation, and even blood vessel growth.
How TRPV1 Was Discovered
For decades, scientists knew capsaicin caused a burning sensation but had no idea which molecular sensor was responsible. In 1997, David Julius and colleagues used an expression-cloning strategy on rat dorsal root ganglion neurons to isolate the gene encoding a capsaicin receptor, launching the modern era of molecular pain research.1Frontiers in Cellular Neuroscience. Beyond Neuronal Heat Sensing: Diversity of TRPV1 Heat-Capsaicin Receptor-Channel Functions That work eventually contributed to Julius winning the Nobel Prize in Physiology or Medicine in 2021. The receptor was initially called VR1 (vanilloid receptor 1) before being reclassified under the TRP superfamily as TRPV1.
The Physical Shape of the Channel
TRPV1 sits in the cell membrane of sensory neurons and assembles from four identical protein subunits arranged symmetrically around a central pore. High-resolution imaging using electron cryo-microscopy revealed that the pore itself is formed by the fifth and sixth transmembrane segments of each subunit, connected by a short loop that determines which ions can pass through. Surrounding these pore-forming segments are voltage-sensor-like domains, and the whole structure features a wide extracellular “mouth” leading down to a short, narrow selectivity filter that favors positively charged ions like calcium and sodium.2PubMed Central. Structure of the TRPV1 ion channel determined by electron cryo-microscopy
On the inside of the cell, each subunit extends a long tail studded with structures called ankyrin repeats, which help the four subunits lock together and provide docking sites for regulatory molecules. A conserved region called the TRP domain connects to the linker between the fourth and fifth transmembrane segments, acting as a kind of lever that different stimuli can pull to open or close the channel.2PubMed Central. Structure of the TRPV1 ion channel determined by electron cryo-microscopy This architecture explains one of TRPV1’s most interesting properties: multiple very different stimuli can all converge on the same gate.
What Opens the Channel
TRPV1 is sometimes called a polymodal receptor because it responds to several categories of stimulus rather than just one. The three classical triggers are temperatures above roughly 43 °C (about 109 °F), acidic conditions (low pH), and capsaicin-like chemicals.3PubMed. Structure and function of TRPV1 Each of these activates the channel through a somewhat different route on the protein, but they all converge on the same central gate. That convergence has a practical consequence: a combination of mild heat and a small amount of capsaicin can open the channel more effectively than either stimulus alone.4PubMed Central. Selective disruption of high sensitivity heat activation but not capsaicin activation of TRPV1 channels by pore turret mutations This is why a warm bowl of spicy soup feels hotter in your mouth than either the temperature or the spice level would predict on its own.
Capsaicin binds in a pocket formed by the transmembrane segments of the channel, locking in place through a mix of hydrogen bonds and close-range molecular interactions. A specific amino acid residue, tyrosine 511, plays a critical role in stabilizing capsaicin once it docks.5PubMed Central. A Potential Route of Capsaicin to Its Binding Site in the TRPV1 Ion Channel Resiniferatoxin, a compound from the cactus-like Euphorbia resinifera plant, binds in the same general pocket but is far more potent than capsaicin, a difference researchers have exploited therapeutically.6PubMed Central. Resiniferatoxin for Pain Treatment: An Interventional Approach to Personalized Pain Medicine
Dietary Compounds That Trigger TRPV1
Capsaicin gets the headlines, but it is far from the only kitchen ingredient that activates TRPV1. Researchers have catalogued a broad list of food-derived agonists, including capsiate and capsiconiate from sweet peppers, several piperine-related compounds from black pepper, gingerols and shogaols from ginger, and sanshools from sansho (Japanese pepper).7PubMed. Food Compounds Activating Thermosensitive TRP Channels in Asian Herbal and Medicinal Foods The tingling warmth you feel from fresh ginger or the numbing buzz of Sichuan peppercorns both involve TRPV1 to varying degrees, though Sichuan peppercorns also recruit other TRP channels for their distinctive mouth-numbing effect. In practical terms, a wide swath of Asian herbal and medicinal ingredients converge on this same receptor family, which helps explain why cuisines that evolved independently on different continents still tend to pair “hot” spices together.
Endogenous Activators Inside Your Body
Your body does not wait for you to eat a chili pepper to use TRPV1. Several internally produced lipid molecules, sometimes called endovanilloids, activate the channel on their own. The best-known is anandamide (N-arachidonoyl ethanolamine), an endocannabinoid that also binds cannabinoid receptors in the brain. Beyond anandamide and its close relatives, at least two other lipid families activate TRPV1: unsaturated long-chain N-acyldopamines and certain metabolites of arachidonic acid produced by lipoxygenase enzymes.8PubMed. Biochemistry and pharmacology of endovanilloids
The picture that emerges is less one of a “promiscuous” receptor that opens for anything, and more of an opportunistic one. TRPV1 exploits the structural similarity among a narrow range of lipid molecules the body naturally produces, responding to slight variations on the same chemical theme.9PubMed Central. Opportunistic activation of TRP receptors by endogenous lipids: exploiting lipidomics to understand TRP receptor cellular communication One such endogenous activator, N-arachidonoyl-dopamine (NADA), sits at the intersection of the pain and cannabinoid systems because it activates both TRPV1 and CB1 receptors on sensory nerve fibers.10PubMed. TRPV1 and CB(1) receptor-mediated effects of the endovanilloid/endocannabinoid N-arachidonoyl-dopamine on primary afferent fibre and spinal cord neuronal responses in the rat This dual identity is part of why the relationship between pain and the endocannabinoid system remains a rich and complicated research area.
How TRPV1 Signals Pain
When TRPV1 opens on a pain-sensing nerve ending, calcium and sodium ions rush into the cell, generating an electrical signal that travels up to the spinal cord and then to the brain. Many of these nerve fibers are thin, unmyelinated C-fibers or lightly myelinated A-delta fibers, the types responsible for the slow burn or the sharp initial sting of pain, respectively. TRPV1 expression is a defining feature of a large proportion of nociceptors. In mice engineered to express a fluorescent marker in TRPV1-lineage neurons, about 44% of those neurons also carried calcitonin gene-related peptide, a marker of peptidergic nociceptors that play a central role in inflammation and migraine.11Cell Reports. TRPV1 Nociceptor Activity Initiates USP5/T-type Channel-Mediated Plasticity
The functional importance of these fibers was demonstrated in a human study where high-concentration capsaicin was applied to the skin to temporarily knock out TRPV1-positive nerve endings. With those fibers silenced, experimentally induced pain amplification dropped by about half, and the surrounding area of heightened sensitivity shrank by roughly three-quarters.12Brain. Capsaicin-sensitive C- and A-fibre nociceptors control long-term potentiation-like pain amplification in humans The implication is that TRPV1-bearing fibers are not just involved in detecting a painful stimulus at the site of injury; they help amplify and spread the pain signal in the spinal cord.
When TRPV1 Gets Sensitized During Inflammation
If you have ever noticed that an inflamed area of skin feels painfully hot even at normal temperatures, TRPV1 sensitization is a likely contributor. During inflammation, the body releases prostaglandins and other signaling molecules that activate enzymes called protein kinases inside the nerve cell. Protein kinase C (PKC) and protein kinase A (PKA) can add phosphate groups to specific sites on the TRPV1 protein. This chemical modification lowers the temperature threshold at which the channel opens, meaning body heat alone may be enough to trigger pain signaling.13PubMed Central. Role of Src kinase in regulating protein kinase C mediated phosphorylation of TRPV1
Prostaglandins E2 and I2, two of the most abundant inflammatory mediators, sensitize TRPV1 through their respective receptors, predominantly via PKC.14PubMed Central. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins Researchers have even pinpointed one critical phosphorylation site: serine 800, which is a substrate for a specific isoform of PKC called PKCε. The amount of PKCε present in the cell directly tracks with how much TRPV1 gets phosphorylated at that site.15PubMed. Increased sensitivity of desensitized TRPV1 by PMA occurs through PKCepsilon-mediated phosphorylation at S800 This mechanism explains why anti-inflammatory drugs that suppress prostaglandin production can reduce pain: they are, in part, preventing TRPV1 from becoming hyper-responsive.
Why Spicy Food Stops Hurting
If capsaicin activates a pain receptor, why does the burning eventually fade, and why do people who eat spicy food regularly seem to tolerate it better? The answer involves desensitization, a process where prolonged or repeated activation of TRPV1 actually shuts the channel down temporarily.
The key player is a membrane lipid called PIP2 (phosphatidylinositol 4,5-bisphosphate). When capsaicin opens TRPV1 and calcium floods in, the calcium activates an enzyme called phospholipase C, which chews up PIP2 in the surrounding membrane. As PIP2 levels drop, TRPV1 loses the membrane environment it needs to stay responsive and becomes desensitized.16PubMed Central. Dual regulation of TRPV1 by phosphoinositides Real-time imaging of PIP2 levels in the membrane has shown that the depletion follows a rapid time course closely synchronized with the decline in TRPV1 current, and the extent of depletion is substantial enough to account for the loss of sensitivity.17PLoS Biology. Interaction with Phosphoinositides Confers Adaptation onto the TRPV1 Pain Receptor
Recovery from desensitization requires the cell to resynthesize PIP2. When researchers blocked the enzyme responsible for making new PIP2 (phosphatidylinositol-4-kinase), recovery was abolished, confirming that replenishing this lipid is the rate-limiting step in getting TRPV1 back online.18PubMed Central. Functional recovery from desensitization of vanilloid receptor TRPV1 requires resynthesis of phosphatidylinositol 4,5-bisphosphate This built-in off-switch is part of why capsaicin-based creams work for pain relief: the initial burn activates TRPV1, but sustained exposure depletes the nerve ending’s ability to keep signaling.
Neurogenic Inflammation and Substance P
TRPV1 does not just relay pain signals upstream to the brain. When TRPV1-positive nerve endings fire, they also release inflammatory molecules locally, a process called neurogenic inflammation. One of the most important of these molecules is substance P, a neuropeptide that acts on nearby cells to cause redness, swelling, and warmth. In the gut, for instance, ethanol activates TRPV1 on sensory nerves, triggering the release of substance P, which then stimulates nearby epithelial cells to produce damaging reactive oxygen species. Blocking TRPV1 in animal studies prevented this alcohol-triggered substance P release.19PubMed. Substance P released by TRPV1-expressing neurons produces reactive oxygen species that mediate ethanol-induced gastric injury This mechanism helps explain why heavy alcohol consumption irritates the stomach lining and why some people experience a burning sensation in the gut after drinking.
How Ion Flow Through the Pore Actually Behaves
Single-channel recordings of TRPV1 reveal that the pore is far from a simple on-off switch. When the channel is open, it undergoes rapid flickers between open and partially closed states, producing excess noise in the electrical current. These flickers become more pronounced when the channel is conducting larger ions, suggesting that the permeating ion itself physically interacts with the narrowest part of the pore and briefly disrupts flow.20Journal of General Physiology. Permeant cations modulate pore dynamics and gating of TRPV1 ion channels In other words, the selectivity filter that determines which ions pass through is not a rigid ring. It fluctuates structurally, and the ions passing through it actually influence how fast it flickers. This dynamic pore behavior adds another layer of regulation to how much signal the channel ultimately produces.
Beyond Neurons: TRPV1 in Blood Vessels and Other Tissues
Although TRPV1 is best known as a pain receptor on nerve cells, it is also expressed on the endothelial cells that line blood vessels, where it plays a surprisingly different role. Endothelial TRPV1 contributes to angiogenesis, the growth of new blood vessels, by promoting endothelial cell migration, proliferation, and the formation of tube-like structures.21PubMed Central. Endothelial TRPV1 as an Emerging Molecular Target to Promote Therapeutic Angiogenesis Research has also linked endothelial TRPV1 to antioxidant effects. Caffeic acid phenethyl ester (CAPE), a compound derived from bee propolis, activates TRPV1 on microvascular endothelial cells, triggering a calcium influx that drives a measurable reduction in oxidative stress inside the cell.22PubMed Central. The antioxidant property of CAPE depends on TRPV1 channel activation in microvascular endothelial cells
TRPV1 expression has been documented in the airways, the gut, and the urinary bladder, among other tissues. Patients with chronic obstructive pulmonary disease (COPD) and chronic cough show increased TRPV1 expression in their airways, and the channel is implicated in irritable bowel syndrome (IBS) and other gastrointestinal conditions.23Journal of Exploratory Research in Pharmacology. Role of TRPV1 in Health and Disease The fact that TRPV1 shows up in so many tissue types makes it an attractive but tricky drug target, because blocking it everywhere has unintended consequences.
Why Birds Can Eat Chili Peppers
Birds famously devour hot peppers without discomfort, and the explanation turns on a remarkably subtle difference in TRPV1’s protein sequence. In the chicken version of TRPV1, the amino acid at a key position in the region linking the fourth and fifth transmembrane segments is an alanine. In rats, the equivalent position holds a glutamic acid. Researchers showed that simply swapping that single amino acid, changing the chicken’s alanine 578 to a glutamic acid, was enough to make the chicken receptor respond to capsaicin at micromolar concentrations.24Scientific Reports. A single TRPV1 amino acid controls species sensitivity to capsaicin Even substituting other amino acids at that spot (lysine, glutamine, or proline) restored some capsaicin sensitivity. The finding illustrates how evolution can fine-tune a receptor’s chemical sensitivity with minimal genetic change, and it explains why chili plants may have evolved capsaicin production to deter mammals while still relying on birds for seed dispersal.
The Thermoregulation Problem With TRPV1-Based Drugs
Because TRPV1 plays a central role in pain, pharmaceutical companies have invested heavily in TRPV1 antagonists, drugs that block the channel to silence pain signals. Early candidates worked well as analgesics in preclinical testing, but many caused a dangerous side effect: hyperthermia, a rise in core body temperature. The underlying issue is that TRPV1 is tonically active in thermoregulatory circuits. Under normal conditions, endogenous activators keep TRPV1 slightly open, providing input that the body uses to keep its temperature in check. Block that tonic signal, and body temperature drifts upward.25PubMed. Turning down the body heat: A novel mechanism for TRPV1 antagonist-induced hyperthermia This side effect stalled multiple drug programs and forced the field to rethink its approach.
One promising strategy involves biased allosteric modulators, compounds that affect TRPV1’s pain-related functions without disrupting its role in temperature regulation. Researchers recently identified a compound, PSFL2874, that achieves pain relief by binding to a site on TRPV1 that does not overlap with the vanilloid pocket critical for thermoregulation. The existence of such a compound demonstrates that TRPV1’s pain and temperature functions can be separated pharmacologically.26Neuron. Biased allosterism of TRPV1 facilitates the development of non-opioid analgesics Given the ongoing opioid crisis, a non-opioid analgesic that targets TRPV1 without causing fever would be a significant clinical advance.
Resiniferatoxin as a Pain Therapy
Rather than blocking TRPV1, an alternative approach overactivates it so severely that the nerve ending is functionally destroyed. Resiniferatoxin (RTX), the ultra-potent TRPV1 agonist from Euphorbia resin, can ablate TRPV1-positive nerve terminals when injected locally, producing long-lasting pain relief without affecting other types of sensation like touch or pressure. In a rat model of burn injury, a single local injection of RTX reversed pain-related behaviors within 24 hours, and the analgesic effect persisted through the three-week recovery period.27Pain Medicine. Local Resiniferatoxin Induces Long-Lasting Analgesia in a Rat Model of Full Thickness Thermal Injury The burn wound itself healed normally, showing that eliminating TRPV1-bearing nerve endings at the site did not interfere with tissue repair. RTX is currently being tested in human clinical trials for severe cancer pain and other conditions where conventional analgesics fall short, and its duration of action could make it particularly useful for patients who need sustained relief without repeated dosing.6PubMed Central. Resiniferatoxin for Pain Treatment: An Interventional Approach to Personalized Pain Medicine